About
Our Medicine
Science
& Pipeline
Patients
Healthcare
Professionals
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
About
Our Medicine
Science
& Pipeline
Patients
Healthcare
Professionals
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
26ᵗʰ European Hematology Association (EHA) Annual Congress
26ᵗʰ European Hematology Association (EHA) Annual Congress
June 2021
Preliminary Clinical Data From a Phase 1b Study of Mavorixafor and Ibrutinib in Patients With Waldenström’s Macroglobulinemia With MYD88 and CXCR4 Mutations
© Copyright 2024 X4 Pharmaceuticals. All Rights Reserved.
Terms of Use
|
Privacy
|
Compliance and Ethics